Cargando…

Genome-wide bioinformatics analysis reveals CTCFL is upregulated in high-grade epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy that threatens the health of females. Previous studies have demonstrated that the survival outcomes of patients with different EOC grades varied. Therefore, the EOC grade is considered to serve as a distinctive prognostic fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Mi, Yan, Changsheng, Jiang, Yi, Meng, Huangyang, Feng, Mingming, Cheng, Wenjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732990/ https://www.ncbi.nlm.nih.gov/pubmed/31516605 http://dx.doi.org/10.3892/ol.2019.10736

Ejemplares similares

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis
por: Liu, Jinhui, et al.
Publicado: (2019)

Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6
por: Gong, Mi, et al.
Publicado: (2019)

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2011)

Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation
por: Nishana, Mayilaadumveettil, et al.
Publicado: (2020)

The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
por: Salgado-Albarrán, Marisol, et al.
Publicado: (2019)

BORIS (CTCFL) Is Not Expressed in Most Human Breast Cell Lines and High Grade Breast Carcinomas
por: Hines, William C., et al.
Publicado: (2010)

Early vertebrate origin of CTCFL, a CTCF paralog, revealed by proximity-guided shark genome scaffolding
por: Kadota, Mitsutaka, et al.
Publicado: (2020)

Author Correction: Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation
por: Nishana, Mayilaadumveettil, et al.
Publicado: (2020)

The Evolution of Epigenetic Regulators CTCF and BORIS/CTCFL in Amniotes
por: Hore, Timothy A., et al.
Publicado: (2008)

Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells
por: Jones, Tania A., et al.
Publicado: (2011)

BORIS/CTCFL is an RNA-binding protein that associates with polysomes
por: Ogunkolade, Babatunji W, et al.
Publicado: (2013)

BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells
por: Renaud, Stéphanie, et al.
Publicado: (2011)

CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
por: Salgado-Albarrán, Marisol, et al.
Publicado: (2022)

Analysis of adverse events and quality of life in high-grade serous ovarian cancer patients with Olaparib maintenance therapy: A single-center study in China
por: Jiang, Yi, et al.
Publicado: (2023)

Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells
por: Alberti, Loredana, et al.
Publicado: (2015)

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
por: Nie, Sipei, et al.
Publicado: (2021)

Choice of binding sites for CTCFL compared to CTCF is driven by chromatin and by sequence preference
por: Bergmaier, Philipp, et al.
Publicado: (2018)

Molecular Lesions of Insulator CTCF and Its Paralogue CTCFL (BORIS) in Cancer: An Analysis from Published Genomic Studies
por: Voutsadakis, Ioannis A.
Publicado: (2018)

CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity
por: Zambrano-Galván, Graciela, et al.
Publicado: (2014)

A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors
por: Loukinov, Dmitri, et al.
Publicado: (2023)

ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
por: Nie, Sipei, et al.
Publicado: (2021)

BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells
por: Janssen, Sanne Marlijn, et al.
Publicado: (2020)

The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements
por: Pugacheva, Elena M., et al.
Publicado: (2016)

Transcription Factor CTCFL Promotes Cell Proliferation, Migration, and Invasion in Gastric Cancer via Activating DPPA2
por: Yao, Haibo, et al.
Publicado: (2021)

The Testis-Specific Factor CTCFL Cooperates with the Protein Methyltransferase PRMT7 in H19 Imprinting Control Region Methylation
por: Jelinic, Petar, et al.
Publicado: (2006)

High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells
por: Alberti, Loredana, et al.
Publicado: (2014)

BRCA mutation in high grade epithelial ovarian cancers
por: Manchana, Tarinee, et al.
Publicado: (2019)

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene
por: Hoivik, Erling A., et al.
Publicado: (2014)

ITLNI identified by comprehensive bioinformatic analysis as a hub candidate biological target in human epithelial ovarian cancer
por: Liu, JinHui, et al.
Publicado: (2019)

Identification of Genes and Pathways Involved in Ovarian Epithelial Cancer by Bioinformatics Analysis
por: Zhou, Yun, et al.
Publicado: (2018)

Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics
por: Alur, Varun Chandra, et al.
Publicado: (2019)

Bioinformatics challenges for genome-wide association studies
por: Moore, Jason H., et al.
Publicado: (2010)

Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities
por: Liu, GuiFen, et al.
Publicado: (2020)

No Evidence for Mutations of CTCFL/BORIS in Silver-Russell Syndrome Patients with IGF2/H19 Imprinting Control Region 1 Hypomethylation
por: Bernier-Latmani, Jeremiah, et al.
Publicado: (2009)

Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells
por: Zhou, Qi, et al.
Publicado: (2015)

Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
por: Yang, Fan, et al.
Publicado: (2015)

Intraoperative Cytology of Ovarian Neoplasms with an Attempt to Grade Epithelial Tumors
por: Bohara, Sangita, et al.
Publicado: (2018)

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2019)

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
por: Gao, Bo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_brcknbl9uu0sqetfi11aq3m6cu